Quality Drafting Group

The Quality Drafting Group (DG Q) was established at the first meeting of the Committee on Herbal Medicinal Products (HMPC) in September 2004, as a temporary subgroup of the committee.

The role of the DG Q is to provide support to the HMPC in the area of quality. Its responsibilities include updating and developing guidance addressing specific quality issues related to herbal medicinal products. Where appropriate, the DG Q co-ordinates its work with the Quality Working Party.

Mandate, rules of procedure and work programme

EMA has temporarily suspended or scaled back certain activities since 2019 based on EMA’s business continuity plan and during the COVID-19 pandemic. DG Q is set for reorganisation in 2023, as part of EMA's revised operating model for working parties. Until then, DG Q continues to work under its current mandate.

The DG Q operates under the mandate of the HMPC.

More information on the DG Q's responsibilities and composition are available in this document:

Mandate, objectives and rules of procedure for HMPC temporary working parties and drafting groups

Adopted Reference Number: EMEA/HMPC/410043/2008 Rev. 2

Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)

Adopted Reference Number: EMA/HMPC/460661/2023

Composition

The DG Q is composed of 9 members.

Members

Below (in alphabetical order of surname) are the current members of DG Q. The members' declarations of interests are available in the European expert list.

• Stefanie Bodemann
• Mirna Galovic
• Kristine Hvolby
• Sari Koski
• Astrid Obmann
• Olga Maria Palomino
• Carmen Purdel (Chair)
• Anna Maria Serrilli
• Friederike Stolte